Va. company creates 'game-changer' injection for opioid use disorder

RICHMOND, Va. – In November, the FDA approved Sublocade, a first of its kind treatment developed by a Richmond-based pharmaceutical company Indivior for moderate to severe opioid disorder. “It's a sustained release buprenorphine injection that releases plasma concentrations of the medication ...